stockrowOutlook Therapeutics, Inc. (OTLK) vs Voyager Therapeutics, Inc. (VYGR)
- Outlook Therapeutics, Inc. OTLK 0.43 −2.27%
- Voyager Therapeutics, Inc. VYGR 1.90 +10.47%
Outlook Therapeutics, Inc. and Voyager Therapeutics, Inc. are both Biotechnology companies. Outlook Therapeutics, Inc. and Voyager Therapeutics, Inc. are of similar size ($106.9M and $106.0M). Voyager Therapeutics, Inc. grew revenue faster over the last twelve months: −19.8% against −113.6%. Outlook Therapeutics, Inc. has the higher net margin (5,253.4% vs −416.3%) and the higher return on invested capital (0.00% vs −249.6%). Across the 16 metrics below, Outlook Therapeutics, Inc. leads on 11 and Voyager Therapeutics, Inc. on 5.
Valuation
Profitability
| Metric | OTLK | VYGR | Biotechnology median |
|---|---|---|---|
| Gross margin | 195.62% | 100.00% | 68.51% |
| Operating margin | 4,781.76% | (450.12%) | 0.00% |
| Net margin | 5,253.40% | (416.32%) | 0.00% |
| Free cash flow margin | 4,826.38% | (434.88%) | 0.00% |
| Return on equity | 256.92% | (58.90%) | (51.96%) |
| Return on assets | (251.66%) | (44.92%) | (46.06%) |
| Return on invested capital | 0.00% | (249.55%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack